Mycophenolate mofetil in renal transplantation: five years experience.
Tuncer
M
M
Akdeniz University Medical School, Department of Nephrology, Antalya, Turkey.
Gürkan
A
A
Erdoğan
O
O
Demirbaş
A
A
Süleymanlar
G
G
Ersoy
F F
FF
Akaydin
M
M
Yakupoğlu
G
G
D000328:Adult; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016019:Survival Analysis; D014019:Tissue Donors / Q000706:statistics & numerical data; D014421:Turkey
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D001379:Azathioprine